Analysis of risk factors for dry eye disease and effect of diquafosol sodium ophthalmic solution on the tear film after vitrectomy in patients with type 2 diabetes mellitus: a preliminary study

被引：0
|
作者：
Xing Du
Zhen Yang
Yuanyuan Guo
Shanshan Li
Xu Wang
Yanjuan Sheng
Min Du
机构：
[1] Jinan Second People’s Hospital,
[2] Huaiyin District,undefined
来源：
International Ophthalmology | 2023年 / 43卷
关键词：
Diabetes mellitus; Dry eye; Tear film; Diquafosol sodium; Vitrectomy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1849 / 1859
页数：10
相关论文
共 50 条
  • [41] Trends in vascular risk factors and medication use in patients with various manifestations of vascular diseases or type 2 diabetes mellitus from 1996 to 2007: the Second Manifestations of ARTerial disease study
    Vlek, Anne
    Visseren, Frank
    Algra, Ale
    Soedamah-Muthu, Sabita
    Moll, Frans
    Doevendans, Pieter
    Kappelle, Jaap
    van der Graaf, Yolanda
    EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2010, 17 (06): : 628 - 636
  • [42] Prevalence and risk factors of cognitive dysfunction in patients with type 2 diabetes mellitus receiving care in a reference hospital in Cameroon: a cross-sectional study
    Abba, Zainab I.
    Mboue-Djieka, Yannick
    Mapoure, Yacouba N.
    Nkouonlack, Cyrille
    Luma, Henry N.
    Choukem, Simeon-Pierre
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2018, 38 (02) : 158 - 164
  • [43] Risk factors for type 2 diabetes mellitus among out-patients in Ho, the Volta regional capital of Ghana: A case-control study
    Gudjinu H.Y.
    Sarfo B.
    BMC Research Notes, 10 (1)
  • [44] Difference Analysis Of Related Factors In Macrovascular And Microvascular Complications In Chinese Patients With Type 2 Diabetes Mellitus: A Case-Control Study Protocol
    Zhao, Hang
    Shu, Linyi
    Huang, Wenli
    Wang, Wenzhao
    Song, Guangyao
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2019, 12 : 2193 - 2200
  • [45] Beneficial effect of lixisenatide after 76 weeks of treatment in patients with type 2 diabetes mellitus: A meta-analysis from the GetGoal programme
    Broglio, Fabio
    Mannucci, Edoardo
    Napoli, Raffaele
    Nicolucci, Antonio
    Purrello, Francesco
    Nikonova, Elena
    Stager, William
    Trevisan, Roberto
    DIABETES OBESITY & METABOLISM, 2017, 19 (02): : 248 - 256
  • [46] A Study to Evaluate the Effect of Sodium-Glucose Co-transporter 2 (SGLT2) Inhibitors on Oxidative Stress Parameters in Type 2 Diabetes Mellitus Patients
    Sharma, Ankita
    Aruna, D.
    Beatrice, Anne
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
  • [47] ANALYSIS OF RISK FACTORS FOR COVID-19-RELATED FATAL OUTCOME IN 337991 PATIENTS WITH TYPE 1 AND TYPE 2 DIABETES MELLITUS IN 2020-2022 YEARS: RUSSIAN NATIONWIDE RETROSPECTIVE STUDY
    Mokrysheva, Natalya G.
    Shestakova, Marina, V
    Vikulova, Olga K.
    Elfimova, Alina R.
    Isakov, Mikhail A.
    Gins, Nikolai A.
    Deviatkin, Andrei A.
    Dedov, Ivan I.
    DIABETES MELLITUS, 2022, 25 (05): : 404 - 417
  • [48] Control of Risk Factors for Cardiovascular Disease Among Adults with Previously Diagnosed Type 2 Diabetes Mellitus: A Descriptive Study from a Middle Eastern Arab Population
    Al-Lawati, Jawad A.
    Barakat, Mohammed N.
    Al-Zakwani, Ibrahim
    Elsayed, Medhat K.
    Al-Maskari, Masoud
    Al-Lawati, Nawar M.
    Mohammed, Ali Jaffer
    OPEN CARDIOVASCULAR MEDICINE JOURNAL, 2012, 6 : 133 - 140
  • [49] Sodium-glucose cotransporter-2 inhibitor in risk of sepsis/septic shock among patients with type 2 diabetes mellitus—a retrospective analysis of nationwide medical claims data
    Wei-Syun Hu
    Cheng-Li Lin
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2024, 397 : 1623 - 1631
  • [50] Effect of Sodium-Glucose Cotransporter-2 Inhibitors versus Dipeptidyl Peptidase 4 Inhibitors on Cardiovascular Function in Patients with Type 2 Diabetes Mellitus and Coronary Artery Disease
    Lee, Sook Jung
    Lee, Kook Hyung
    Oh, Hyun Geong
    Seo, Hye Ji
    Jeong, Soo Jin
    Kim, Chong Hwa
    JOURNAL OF OBESITY & METABOLIC SYNDROME, 2019, 28 (04) : 254 - 261
12345